Navigation Links
Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
Date:9/30/2009

atalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including the Company's ability to successfully obtain the financing required to perform future clinical trials of CPP-109 evaluating its use in the treatment of cocaine addiction and methamphetamine addiction, the Company's ability to successfully complete such future clinical trials that it determines to undertake, the Company's ability to successfully conduct such additional number of trials as may be required to file an NDA for CPP-109, and those other factors described in the Company's filings with the U.S. Securities and Exchange Commission (SEC), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.

SOURCE Catalyst Pharmaceutical Partners


'/>"/>
SOURCE Catalyst Pharmaceutical Partners
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
2. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
3. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
4. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
5. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
6. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
7. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
8. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
9. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
10. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
11. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... has received an AB therapeutic equivalent rating from the ... approved New Drug Application (NDA) for testosterone gel 1.0%. ... to [AbbVie,s] AndroGel 1% and can be substituted with ... clinical effect and safety profile as AndroGel 1% when ...
(Date:7/24/2014)... 24, 2014 Talyst, a market leader in ... Association of State Veterans Homes (NASVH) Summer Conference in ... of the NASVH is to ensure that each and ... term health care and respect which they have earned ... the InSite® Remote Dispensing System, Talyst can help State ...
(Date:7/24/2014)... Calif. , July 24, 2014  Lazarus ... development of novel interventional devices to facilitate removal ... States Patent and Trademark Office has issued a ... technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever (stentriever) ...
Breaking Medicine Technology:Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... Results Expected in November 2008, BOTHELL, Wash., Oct. ... today the completion of patient enrollment and dosing,for the ... safety and,efficacy of its formulation of 12-hour extended-release (ER) ... report top-line,results from this pivotal trial in November 2008. ...
... world,s most influential medical journal, the New England Journal,of ... company,s study,of the Diamyd(R) diabetes vaccine for type 1 ... article is now available on the journal,s web site,( ... 30. It presents the,results of the concluded Phase II ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4
(Date:7/25/2014)... Steven Reinberg HealthDay ... An "unacceptably low" number of girls and boys are getting ... and other cancers, U.S. health officials said Thursday. The ... and girls aged 11 and 12 get the three-dose vaccine ... active. Yet, despite a slight increase ...
(Date:7/25/2014)... July 25, 2014 Home Care Assistance ... provider of non-medical, in-home senior care, is weighing in ... be supporting senior-led projects in Alberta through their New ... for Seniors Program is a federal grants and contributions ... who make a difference in the lives of others ...
(Date:7/25/2014)... one of the leading dress manufacturers and retailers, has ... for women. In addition, the reliable supplier has ... They are available at discounted rates, up to 58% ... “We are pleased to announce our new range of ... number of stylish special occasion gowns for sale, including ...
(Date:7/25/2014)... July 25, 2014 Ticket Down ... International Champions Cup Match between Manchester City and Liverpool ... one of the most iconic locations is Yankee Stadium. It ... but it is quickly becoming a location that any major ... home to the New York Yankees from Major League Baseball, ...
(Date:7/25/2014)... Mahendra Trivedi and his wife Dahryn ... is Power’ on Saturday, July 26, 2014. People from ... life transforming event as they will get a chance ... days are left for the commencement of this rare ... Masters™ Dahryn Trivedi (his wife) and Alice Branton will ...
Breaking Medicine News(10 mins):Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 2Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 3Health News:Famous Supplier Stwd.co.uk Announces Its New Selection of Evening Dresses for Women 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3
... used to strengthen weak muscles that can lead to urinary leakage. ... ... Hospital ( http://www.beaumonthospitals.com ) are first in the United States to treat ... study. The stem cells are used to strengthen weak muscles that control ...
... Joins Florida Renal Coalition, National Kidney Foundation of Florida ... Insurance for Florida,s Most Vulnerable Kidney Patients, and to ... Fla., March 10 Former Miami Heat stand-out and ... is also a kidney transplant recipient, participated in numerous ...
... PLAINS, N.Y., March 10 The Leukemia & Lymphoma ... through its Give & Get program, to raise funds ... initiatives.LLS is one of six nonprofit organizations that Gap ... Get promotion. For three days in March, Gap Inc. ...
... March 10, 2009 A simple balance test may ... study published in the March 2009 issue of the ... was carried out in 16 university hospital departments of ... outpatients suffering from AD. This population is representative of ...
... Lives with 10-Sessions for Permanent Weight LossNEW YORK, March ... work. It,s called The Caryl Ehrlich Program, and it ... Instead of countless diets, The Program teaches participants one-on-one ... word to lose weight and keep it off forever.The ...
... Mobile Massage Team ( www.mobilemassageteam.com ), a leading provider ... promotional events, and special affairs, today announced that the ... 2009 Trade Fair ( http://www.lehighvalleychamber.org ) at Northampton Community ... noon - 6:00 pm. Team members will be ...
Cached Medicine News:Health News:Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence 2Health News:Miami Heat Fan Favorite and NBA All-Star Alonzo Mourning Visits Florida Legislature, Governor to Urge Needed Coverage for Florida Kidney Patients 2Health News:Miami Heat Fan Favorite and NBA All-Star Alonzo Mourning Visits Florida Legislature, Governor to Urge Needed Coverage for Florida Kidney Patients 3Health News:Miami Heat Fan Favorite and NBA All-Star Alonzo Mourning Visits Florida Legislature, Governor to Urge Needed Coverage for Florida Kidney Patients 4Health News:Gap Inc., The Leukemia & Lymphoma Society Encourage Shoppers to Support Cancer-Fighting Programs 2Health News:A simple balance test may predict cognitive decline in Alzheimer's disease 2Health News:Behavioral Approach to Weight Loss 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: